Skip to Main Content
Yale School of Medicine
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Yale School of Medicine
/
Internal Medicine
/
Medical Oncology and Hematology
MENU
Yale School of Medicine
MENU
Medical Oncology and Hematology
Support Staff
Faculty
Faculty by Specialty
Patient Care
Research
Clinical Trials
MESH Keyword Search
Publications
Fellowships
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Home
Research
Clinical Trials
MESH Keyword Search
Publications
Clinical Trials Listings
Clinical Trials
Copy Link
Brain and Nervous System
Phase III Trial of Radiotherapy Followed by Adjuvant Temozolomide in Combination With the IDH Inhibitor Vorasidenib vs Placebo in IDH-Mutated Newly-Diagnosed Grade 3 Astrocytomas
Breast
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Principal Investigator: Jing Du
Breast, Ovary, Phase I
Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors
Phase I
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Brain and Nervous System
A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII
Show More
Search Clinical Trials
More Options
Back to Top
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[6602,8330,1568,3053]
{"namedChunks":["modules-page-components-ComponentWrapper","features-generic-content-components-GenericContent","features-clinical-trial-components-ClinicalTrialListing","modules-search-components-SearchBox","modules-footer-components-Footer"]}